Tachibana K - Search Results

1

Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort.

Yano S, Yamada T, Takeuchi S, Tachibana K, Minami Y, Yatabe Y, Mitsudomi T, Tanaka H, Kimura T, Kudoh S, Nokihara H, Ohe Y, Yokota J, Uramoto H, Yasumoto K, Kiura K, Higashiyama M, Oda M, Saito H, Yoshida J, Kondoh K, Noguchi M. Yano S, et al. Among authors: tachibana k. J Thorac Oncol. 2011 Dec;6(12):2011-7. doi: 10.1097/JTO.0b013e31823ab0dd. J Thorac Oncol. 2011. PMID: 22052230 Free article.

2

Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs.

Tanaka H, Kimura T, Kudoh S, Mitsuoka S, Watanabe T, Suzumura T, Tachibana K, Noguchi M, Yano S, Hirata K. Tanaka H, et al. Among authors: tachibana k. Int J Cancer. 2011 Sep 15;129(6):1410-6. doi: 10.1002/ijc.25799. Epub 2011 Feb 26. Int J Cancer. 2011. PMID: 21128242

3

Overexpression of immunoglobulin (CD79a) binding protein1 (IGBP-1) in small lung adenocarcinomas and its clinicopathological significance.

Sakashita S, Li D, Nashima N, Minami Y, Furuya S, Morishita Y, Tachibana K, Sato Y, Noguchi M. Sakashita S, et al. Among authors: tachibana k. Pathol Int. 2011 Mar;61(3):130-7. doi: 10.1111/j.1440-1827.2011.02644.x. Pathol Int. 2011. PMID: 21355954

4

Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.

Tachibana K, Minami Y, Shiba-Ishii A, Kano J, Nakazato Y, Sato Y, Goya T, Noguchi M. Tachibana K, et al. Lung Cancer. 2012 Feb;75(2):181-8. doi: 10.1016/j.lungcan.2011.07.008. Epub 2011 Aug 27. Lung Cancer. 2012. PMID: 21872356

5

Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma.

Nakazato Y, Maeshima AM, Ishikawa Y, Yatabe Y, Fukuoka J, Yokose T, Tomita Y, Minami Y, Asamura H, Tachibana K, Goya T, Noguchi M. Nakazato Y, et al. Among authors: tachibana k. J Thorac Oncol. 2013 Jun;8(6):736-43. doi: 10.1097/JTO.0b013e318288dbd8. J Thorac Oncol. 2013. PMID: 23676557 Free article.

6

A severe combined immunodeficiency disease mouse model of human adenocarcinoma with lepidic-predominant growth.

Tanaka R, Tachibana K, Suda K, Kondo H, Noguchi M. Tanaka R, et al. Among authors: tachibana k. Pathol Res Pract. 2018 Dec;214(12):2000-2003. doi: 10.1016/j.prp.2018.09.021. Epub 2018 Sep 28. Pathol Res Pract. 2018. PMID: 30287185

7

Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid-based cytology.

Tanaka R, Sakamoto N, Suzuki H, Tachibana K, Ohtsuka K, Kishimoto K, Fujiwara M, Kamma H, Shibahara J, Kondo H. Tanaka R, et al. Among authors: tachibana k. Diagn Cytopathol. 2019 Jun;47(6):564-570. doi: 10.1002/dc.24154. Epub 2019 Feb 11. Diagn Cytopathol. 2019. PMID: 30741488

8

Subtyping and EGFR mutation testing from blocks of cytological materials, based on liquid-based cytology for lung cancer at bronchoscopic examinations.

Tanaka R, Ohtsuka K, Ogura W, Arai N, Yoshida T, Nakazato Y, Tachibana K, Takata S, Fujiwara M, Kamma H, Shibahara J, Kondo H. Tanaka R, et al. Among authors: tachibana k. Diagn Cytopathol. 2020 Jun;48(6):516-523. doi: 10.1002/dc.24397. Epub 2020 Mar 3. Diagn Cytopathol. 2020. PMID: 32125777

9

[Subscapular elastofibroma].

Fujita A, Nakazato Y, Tachibana K, Suda K, Yoshida T, Tanaka R, Goya T. Fujita A, et al. Among authors: tachibana k. Kyobu Geka. 2011 May;64(5):390-3. Kyobu Geka. 2011. PMID: 21591441 Japanese.

10

[Thymic metastasis of laryngeal cancer].

Fujita A, Nakazato Y, Tachibana K, Goya T. Fujita A, et al. Among authors: tachibana k. Kyobu Geka. 2011 Sep;64(10):912-5. Kyobu Geka. 2011. PMID: 21899129 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,070 results

Search Page

Filters